On December 24, 2013, Michael Rogers informed Coronado Biosciences, Inc. that he was resigning as a director of company, effective December 26, 2013, due to too many commitments.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 USD | +1.54% | +12.50% | -34.22% |
May. 15 | Earnings Flash (FBIO) FORTRESS BIOTECH Posts Q1 Revenue $13M | MT |
May. 14 | Fortress Biotech Says First Patient Dosed in Phase 2 Study of Triplex | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.22% | 38.08M | |
-2.99% | 89.49B | |
+2.50% | 40.67B | |
-12.01% | 33.15B | |
+63.12% | 26.45B | |
-19.79% | 14.69B | |
-8.58% | 12.89B | |
-12.34% | 11.54B | |
-43.92% | 11.34B | |
+3.75% | 8.84B |
- Stock Market
- Equities
- FBIO Stock
- News Fortress Biotech, Inc.
- Coronado Biosciences, Inc. Announces Resignation of Michael Rogers as Director